Edmund Cannon serves as Executive at CANCER GENETICS, INC, where they oversee executive responsibilities. Since joining the company, Edmund Cannon has executed 5 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 31, 2019 involved purchasing 43,479 shares valued at $10.0K.
Edmund Cannon currently holds 61,873 shares of CANCER GENETICS, INC (CGIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edmund Cannon has been a net buyer of CGIX stock. They have purchased $10.0K and sold $0 worth of shares.
Edmund Cannon's most recent insider trade was on Jan 31, 2019, when they purchased 43,479 shares at $0.23 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 7, 2017 | CGIX | $0 | Award | 2,500 | $N/A | Discretionary |
| Oct 11, 2016 | CGIX | $0 | Award | 2,500 | $N/A | Discretionary |
| May 22, 2014 | CGIX | $0 | Award | 5,000 | $N/A | Discretionary |